Prognostic value of the 6-gene OncoMasTR test in hormone receptor–positive HER2-negative early-stage breast cancer: Comparative analysis with standard clinicopathological factors

Seodhna M. Lynch, Niamh M. Russell, Stephen Barron, Chan-Ju A. Wang, Tony Loughman, Peter Dynoodt, Bozena Fender, Cesar Lopez-Ruiz, Anthony O'Grady, Katherine M. Sheehan, Joanna Fay, Verena Amberger-Murphy, Anurati Saha, Rut Klinger, Claudia A. Gonzalez, Nebras Al-Attar, Arman Rahman, Desmond O'Leary, Fiona T. Lanigan, Adrian P. Bracken, John Crown, Catherine M. Kelly, Darran P. O'Connor, William M. Gallagher

Open source

DOI: 10.1016/j.ejca.2021.04.016
Published: 2021-07
Container: European Journal of Cancer
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ejca.2021.04.016,
  title = {Prognostic value of the 6-gene OncoMasTR test in hormone receptor–positive HER2-negative early-stage breast cancer: Comparative analysis with standard clinicopathological factors},
  author = {Seodhna M. Lynch and Niamh M. Russell and Stephen Barron and Chan-Ju A. Wang and Tony Loughman and Peter Dynoodt and Bozena Fender and Cesar Lopez-Ruiz and Anthony O'Grady and Katherine M. Sheehan and Joanna Fay and Verena Amberger-Murphy and Anurati Saha and Rut Klinger and Claudia A. Gonzalez and Nebras Al-Attar and Arman Rahman and Desmond O'Leary and Fiona T. Lanigan and Adrian P. Bracken and John Crown and Catherine M. Kelly and Darran P. O'Connor and William M. Gallagher},
  year = {2021},
  journal = {European Journal of Cancer},
  doi = {10.1016/j.ejca.2021.04.016},
  url = {https://doi.org/10.1016/j.ejca.2021.04.016}
}

RIS

TY  - JOUR
TI  - Prognostic value of the 6-gene OncoMasTR test in hormone receptor–positive HER2-negative early-stage breast cancer: Comparative analysis with standard clinicopathological factors
AU  - Seodhna M. Lynch
AU  - Niamh M. Russell
AU  - Stephen Barron
AU  - Chan-Ju A. Wang
AU  - Tony Loughman
AU  - Peter Dynoodt
AU  - Bozena Fender
AU  - Cesar Lopez-Ruiz
AU  - Anthony O'Grady
AU  - Katherine M. Sheehan
AU  - Joanna Fay
AU  - Verena Amberger-Murphy
AU  - Anurati Saha
AU  - Rut Klinger
AU  - Claudia A. Gonzalez
AU  - Nebras Al-Attar
AU  - Arman Rahman
AU  - Desmond O'Leary
AU  - Fiona T. Lanigan
AU  - Adrian P. Bracken
AU  - John Crown
AU  - Catherine M. Kelly
AU  - Darran P. O'Connor
AU  - William M. Gallagher
PY  - 2021
JO  - European Journal of Cancer
DO  - 10.1016/j.ejca.2021.04.016
UR  - https://doi.org/10.1016/j.ejca.2021.04.016
ER  -

APA

Lynch, S. M., Russell, N. M., Barron, S., Wang, C. A., Loughman, T., Dynoodt, P., Fender, B., Lopez-Ruiz, C., O'Grady, A., Sheehan, K. M., Fay, J., Amberger-Murphy, V., Saha, A., Klinger, R., Gonzalez, C. A., Al-Attar, N., Rahman, A., O'Leary, D., Lanigan, F. T., Bracken, A. P., Crown, J., Kelly, C. M., O'Connor, D. P., & Gallagher, W. M. (2021). Prognostic value of the 6-gene OncoMasTR test in hormone receptor–positive HER2-negative early-stage breast cancer: Comparative analysis with standard clinicopathological factors. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2021.04.016

Source records

crossref · retrieved 2026-09-26T06:21:05.940Z